Direct‑to‑consumer healthcare services have quietly constructed a parallel infrastructure for medical access. Telehealth platforms prescribe medications after brief video consultations....
Read moreA new kind of literacy is spreading through the public: people can read their own physiologic dashboards. They discuss REM...
Read moreA gleaming solar array atop a hospital wing promises reduced electricity bills and a smaller carbon footprint—but what happens when...
Read moreThe Spectacle of Sickness There is a calculated rhythm to the videos. A grainy close-up of someone solemnly describing their...
Read moreWhen Robert F. Kennedy Jr. released the eagerly anticipated yet deeply contentious MAHA report earlier this year, it instantly polarized...
Read moreFreedom of speech was not designed to help teenagers starve. Yet on TikTok, it often does. A single swipe can...
Read moreIt begins, as many things do now, with a scroll. A 23-year-old nestled in bed with curtains drawn declares, “I’m...
Read moreWalk through a grocery aisle or scroll TikTok’s “wellness” corner, and hydration has never looked so stylish—or so expensive. Rows...
Read moreIt begins in the gut—or so we’re told. Anxiety, weight gain, immunity, even brain fog: according to wellness influencers and...
Read moreMenopause is having a cultural moment—and not a quiet one. From Gwyneth Paltrow’s Goop-endorsed supplements to telehealth hormone therapy startups...
Read moreIt begins with a confession. A young project manager shares on LinkedIn how they took a mental health day after...
Read moreIn the shadow of America’s post-pandemic reckoning, a new health movement has emerged—one that doesn’t wear lab coats or promote...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy